p53 and Tumor Cell Metabolism(报告时间:2010年8月24日上午10:00)

发布时间:2012-08-19

学术报告

报告题目:p53 and Tumor Cell Metabolism
报告人:Xiaolu Yang,Professor, Department of Cancer Biology, University of Pennsylvania
报告时间:2010年8月24日上午10:00
地点:中科院遗传发育所一号楼B210
联系人:许执恒 64806581, zhxu@genetics.ac.cn

Selected Publications from Dr. Yang (通信作者)
1.c-FLIPL is a dual function molecule for caspase-8 activation and CD95-mediated apoptosis. EMBOJ.(2002).
2.Interdimer processing mechanism ofprocaspase-8 activation.EMBO J.(2003).
3.cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosaassociatedlymphoid tissue lymphomas.J. Clinical Investigation(2006).
4.Critical role for Daxx in regulating Mdm2. Nature Cell Biology (2006).
5.The paracaspase MALT1 controls caspase-8 activationduring lymphocyte proliferation. Molecular Cell(2008).
6.tRNA binds to cytochrome c andinhibits caspase activation. Molecular Cell (2010).
7.SUMO E3 ligase activity of TRIM proteins. Oncogene (2011).
8.The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2.JBC. (2011).
9.Siva1 suppresses epithelial-mesenchymaltransition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules. PNAS(2011)
10.p53 regulates biosynthesis throughdirect inactivation of glucose-6-phosphate dehydrogenase. Nature Cell Biology13: 310-18 (2011).


附件下载: